logo Orixha


Octobre 2022

Orixha is laureate of the EIC Accelerator and receives 7,5 M€ for the LuncoLive project.

With Luncolive, Orixha aims to promote the Liquid Ventilation as a new breakthrough technology in critical care.
Orixha announce that its Luncolive program has been selected by the European Innovation Council for a founding of 2.5 M€ and a capital investment of 5 M€, in order to improve the survival of post-cardiac arrest patients. This will allow to validate the clinical benefit of the Vent2Cool Solution in post-cardiac arrest syndrome and to explore and developp new medical applications in critical care

Link to the press release (in french)

March 2022

Orixha won the first prize for innovation at Medi'Nov Salon in Lyon

On march 31st, Orixha won the first prize of Innovation at Medi'Nov salon 2022. This competition was organized by the region Auvergne-Rhône-Alpes in France.

Link to the press release (in french)

Nov 2021

Orixha raises 2 millions euros for the development of the Vent2Cool solution

Orixha just annonced a foundraising of 2 millions euros from Angels Santé, Erganeo and its industrial partners : Infiplast, OEM Development et Activation. This first round will allow to finalize the medical device Vent2Cool before starting the first clinical trial in cardiac arrest patients.

Link to the press release (in french)

Sept 2021

Orixha recieve the financial support of "Programme d'Investissement d'Avenir" after being selected at the I-Nov